SCHEMBL24645264

SCHEMBL24645264

CC(C)(C)OC(=O)N1C[C@@H](Nc2cnccn2)C[C@H]1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.41
ANPEP P15144 2/20 0.41
GPR119 Q8TDV5 7/20 0.40
AGTR2 P50052 1/20 0.36
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
ACHE P22303 1/20 0.34
USP30 Q70CQ3 1/20 0.34
HTRA1 Q92743 1/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
NFKB1 P19838 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24645474 0.80 GPR119 (0.43) MMP2ANPEPGPR119CYP1A2POLB
SCHEMBL2708722 0.79 DPP4 (0.44) GPR119CYP3A4
SCHEMBL1411908 0.78 IMPDH2 (0.39) CYP1A2POLBCYP3A4CYP2C19
SCHEMBL1411900 0.78 IMPDH2 (0.39) CYP1A2POLBCYP3A4CYP2C19
SCHEMBL4570122 0.78 CYP1A2 (0.38) AGTR2CYP1A2POLBCYP3A4CYP2C19
SCHEMBL8183702 0.78 IMPDH2 (0.39) CYP1A2POLBCYP3A4CYP2C19
SCHEMBL13623178 0.77 HTRA1 (0.44) MMP2GPR119AGTR2CYP1A2POLB
SCHEMBL12267629 0.77 HTRA1 (0.44) MMP2GPR119AGTR2CYP1A2POLB
SCHEMBL20135268 0.77 CYP1A2 (0.42) MMP2ANPEPCYP1A2POLBCYP3A4
SCHEMBL29688847 0.77 CYP1A2 (0.42) MMP2ANPEPCYP1A2POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12336991-B2 Factor XIIA inhibitors UNIVERSITY OF LEEDS (GB) 2025-06-24 US disclosed
US-20220305011-A1 FACTOR XIIA INHIBITORS UNIVERSITY OF LEEDS (GB) 2022-09-29 US disclosed
US-20220305011-A1 FACTOR XIIA INHIBITORS UNIVERSITY OF LEEDS (GB) 2022-09-29 US disclosed
CN-112165938-A Factor XIIA inhibitors 利兹大学 2021-01-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220305011-A1 FACTOR XIIA INHIBITORS F11, F13B, F12 MMP2 68/4885ANPEP 244/4885GPR119 4204/4885
US-12336991-B2 Factor XIIA inhibitors F11, F13B, F12 MMP2 68/4885ANPEP 244/4885GPR119 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.